TAIZHOU CITY, China, April 26, 2023 /PRNewswire/ — We are delighted to announce that RayHua (Zhongshan) Pharmaceutical Co., Ltd. has officially become a member of Jiuzhou Pharmaceutical. The move will enhance our CDMO formulation capability, accelerate the implementation of our “API Formulation” integrated platform strategy, and facilitate the rapid launch of high-quality products to better serve our customers in Jiuzhou, Raybow Europe, and Raybow USA.
This integration came after Jiuzhou Pharmaceutical and Sandoz (China) signed a purchase and sale agreement on September 27, 2022 to acquire 100% equity stake in RayHua Zhongshan, a newly established subsidiary of Sandoz (China) to house the site facilities. The acquisition has allowed us to advance our “API Formulation” CDMO strategy.
Prior to the acquisition, Sandoz, a division of Novartis, established the manufacturing site in China. It boasts of world-class formulation production capacity, high-quality management team, advanced production and manufacturing technology, and quality management and operations management systems that meet international standards. The formulation site strictly complies with China’s GMP standards as well as Novartis Group’s global unified quality standards.
This acquisition gives Jiuzhou tight control of the entire process, from supplier development, incoming material testing, product production, finished product testing and launch, adverse effect reporting, and complaint handling. customer complaints to ensure the high quality of products.
With RayHua Zhongshan joining Jiuzhou Pharmaceutical, we will further transform and expand our CDMO formulation project, improve supporting facilities, and build a green factory with low energy consumption, low emission, and high efficiency.
We are excited to welcome RayHua Zhongshan to join our family and look forward to the positive impact this integration will bring to our customers, stakeholders and the healthcare industry at large.
Jiuzhou Pharmaceutical – Caring for Life | Maintaining Health
Logo – https://mma.prnewswire.com/media/972499/4005986/Raybow_Pharmaceutical_Logo.jpg
View original content: https://www.prnewswire.com/news-releases/jiuzhou-pharmaceutical-da-la-bienvenida-a-rayhua-para-que-se-convierta-en-miembro-del-grupo-301808424.html
